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A B S T R A C T
The colonization by Candida species is one of the most important factors related to the development of
oral candidiasis in HIV-infected individuals. The aim of the study was to evaluate and discuss the
phospholipase, proteinase, DNAse and haemolytic activities of Candida albicans isolated from the oral
cavity of HIV individuals with high efﬁciency antiretroviral therapy. Seventy-ﬁve isolates of C. albicans
obtained from saliva samples of patients with HIV and 41 isolates from HIV-negative individuals were
studied. Haemolytic activity was determined in Sabouraud dextrose agar plates containing 3% glucose
and 7% sheep red cells. Culture medium containing DNA base-agar, egg yolk, and bovine albumin were
used to determine DNase, phospholipase and proteinase activities, respectively. All isolates from the HIV
patients group had haemolytic activity, 98% showed phospholipase activity, 92% were positive for
proteinase and 32% DNAse activity. Regarding the group of indivídios HIV negative, all 41 isolates
presented hemolytic activity, 90.2% showed phospholipase and proteinase activity and 12.2% were
positive for DNAse. The phospholipase activity was more intense for the group of HIV positive individuals.
DNase production was more frequently observed in the group of HIV-positive individuals. The percentage
of isolates having DNAse activity was also signiﬁcantly different between the groups of patients not using
any antiretroviral therapy, those using transcriptase inhibitors and those using transcriptase inhibitor
and protease inhibitor in combination.
ã 2016 Elsevier Ltd. All rights reserved.
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Candidiasis manifests when there is an interaction of host- and
yeast-related factors. The factors related to yeast, called pathoge-
nicity or virulence factors, inﬂuence how the infection is presented
and its severity (Riceto, Menezes, Penatti & Pedroso, 2015). Among
the major virulence factor functions that assist in the evasion of
host defences and in the installation and maintenance of infection
are: adhesion of the yeasts and colonisation of mucous membranes
and organs, genotypic and phenotypic variation, growth at
temperatures of 39 C and 42 C and exoenzymes production
(Hube & Naglik, 2001; Souza et al., 2014). The most studied
enzymes are proteases and phospholipases, however Candida spp.
express other factors, still poorly studied and understood, such as* Corresponding author at: Av. s/n , Bloco 6X, 1 Andar, Campus Umuarama,
Uberlândia, MG CEP 38400-902, Brazil.
E-mail address: ralciane2@yahoo.com.br (R. de Paula Menezes).
http://dx.doi.org/10.1016/j.archoralbio.2016.02.004
0003-9969/ã 2016 Elsevier Ltd. All rights reserved.DNAse and haemolysin (Giolo & Svidzinski, 2010; Mohan & Ballal,
2008).
The enzyme phospholipase leads to disruption of the cell
membrane, resulting in the release of lipids (Souza et al., 2014).
Proteases act by degrading various substrates important for
maintaining the body’s physiology, such as albumin, immunoglo-
bulins and proteins of the skin (Sardi et al., 2013; Junqueira et al.,
2012; D’Eça et al., 2011; Mane, Pawale, Gaikwad, Bembalkar &
Risbud, 2011). The lysis of red blood cells caused by the action of a
haemolysin promotes the acquisition of iron (Favero, Furlaneto-
Maia, França, Góes & Furlaneto, 2014; Giolo & Svidzinski, 2010).
Another putative virulence factor is the DNase, that is not yet clear,
but it is believe that is important for promoting DNA degradation of
other microorganisms present in microenvironment (Riceto et al.,
2015; Sánchez & Colom, 2010).
Reduction in the occurrence and severity of oral candidiasis in
patients with Acquired Immunodeﬁciency Syndrome (AIDS) was
observed with the advent of Highly Active Antiretroviral Therapy
(HAART) (De Bernadis et al., 2004). Currently there are six classes
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transcriptase inhibitors, non-nucleoside reverse transcriptase
inhibitors, protease inhibitors, integrase inhibitors, fusion inhib-
itors and co-receptor, which may be prescribed alone or in
combination with each other, depending on the condition of the
patient (Brasil, 2013). According to some authors, some of these
classes, for example, protease inhibitors, may lead to a reduction or
even inhibition of exoenzyme activity of proteinases in Candida
albicans (De Bernadis et al., 2004; Cassone et al., 2002). In this line,
the aims of this study was to evaluate and discuss the activity of
phospholipases, proteinases, DNAse, and haemolytic activities of C.
albicans isolated from the oral cavity of individuals of HIV on high
efﬁciency antiretroviral therapy.
2. Patients and Methods
One hundred and sixteen isolates of C. albicans were studied
including 75 obtained from saliva samples from HIV patients with
no clinical signs of oral candidiasis, and 41 isolates from HIV-
negative individuals.
About 2 mL of saliva was collected directly into sterile tubes.
Saliva samples were plated on Sabouraud Dextrose (Sigma,
Rockville, USA) with the addition of chloramphenicol (100 mg/L)
and chromogenic agar (Conda, Madrid, Spain) and incubated at
30 C for 72 h. The colonies were isolated and subjected to
identiﬁcation by classical methodology: germ tube formation,
microculture agar on tween-80 cornmeal and auxanogram (Lacaz,
Porto, Martins, Heins-Vaccari & Takahashi de Melo, 2002). All
isolates were conﬁrmed by polymerase chain reaction (PCR) using
primers speciﬁc for C. albicans according to Estrada-Barraza et al.
(2011) and Luo and Mitchell (2002). Experimental tests were made
from fresh culture (24–48 h incubation in ASD). A suspension was
made of each isolate in saline solution (0.9%) with a turbidity
equivalent to the McFarland tube 2 scale (1 108 to 5 108
CFU/mL). Aliquots of 5 mL of each suspension were placed at
equidistant points on petri dishes (90  15 mm) containing the
respective culture media: agar phospholipase (Price Wilkinson &
Gentry, 1982), agar proteinase (Ruchel, Tegeller & Trost,1982), agar
DNAse (Sánchez & Colom, 2010) and blood agar (Luo, Samar-
anayake & Yau, 2001; Manns, Mosser & Buckley, 1994). The plates
were incubated at 30 C for four days to search for phospholipase,
for seven days to search for DNAse and proteinase, and for 48 h for
analysis of the haemolytic activity (Sánchez & Colom, 2010; Luo
et al., 2001; Price et al., 1982). The tests were performed in
duplicate and the interpretation and description of the resultsFig. 1. Frequency of isolates of C. albicans oral cavity of positive and HIV-negative inwere performed as proposed by Price et al. (1982) as summarized
below. Phospholipase activity was evidenced by the formation of
an opaque halo around the colony (precipitation of calcium
complexes). Proteinase activity was characterized by the presence
of a whitening halo around the colony on agar albumin resulting
from protein degradation. The activity of the two enzymes was
measured by the ratio of the diameter of the colony (dc) to the
diameter of the colony and the precipitation zone (dcp). The results
were expressed as the ratio dc/dcp for the respective activities: Pz
(phospholipase zone) for phospholipase, Prz (proteinase zone) for
proteinase, and Hi (haemolytic index) for haemolytic activity (Price
et al., 1982). The results were classiﬁed as negative (Pz or Prz or
Hi = 1), moderate (0.63 < Pz or Prz or Hi < 1) and sharp (Pz or Prz or
Hi  0.63). The results for the DNase activity were expressed as
positive or negative depending on the presence or absence of a
clear halo around the colony.
The data relating to the type of antiretroviral therapy used by
the patient at the time of saliva sample collection were obtained by
analysing their medical records.
The Mann–Whitney test was used to compare the enzyme
activities of phospholipase and proteinase, and the haemolytic
activity of C. albicans samples between the two study groups. For
comparing DNase activity the sign test was used. To evaluate if the
type of regimen instituted for the patients inﬂuenced the
expression of the analysed enzymes, one-way ANOVA was used
for phospholipase, haemolysin and proteinase and the binomial
test was used for DNAse. P values < 0.05 were considered to be
signiﬁcant.
3. Results
Fig. 1 shows the frequency of isolates possessing enzyme
activity for each of the four enzymes in the two study groups.
Among the 75 isolates of the C. albicans HIV positive group, it
was observed that 60 (80%) showed a high haemolytic activity, and
the remaining 15 (20%) showed moderate activity. Of the 74
isolates positive for phospholipase, 38 (51.4%) showed marked
activity and 36 (48.6%) moderate activity. Regarding proteinase, 13
(19%) of the C. albicans isolates showed marked activity and in 56
others (81%) this activity was moderate (Table 1).
Among the 41 isolates from the HIV-negative group, it was
found that 82.5% (33) and 17.5% (7) had moderate and high
haemolytic activity, respectively. Regarding phospholipase the
rates were 16.2% (6) with high activity and 83.8% (31) with
moderate activity. The production of protease was marked in 21.7%dividuals, who had haemolytic activity, phospholipase, proteinase and DNAse.
Table 1
Frequency and intensity of haemolytic, phospholipase, proteinase and DNAse activity of C. albicans isolates from the HIV patients group and the control group.
Group Number of isolates (n) Enzyme activity scorea Haemolytic activity scorea
Phospholipase Proteinase DNase
1 2 3 1 2 3 Positive Negative 1 2 3
HIV positive 75 (100%) 1(1.3%) 36(48%) 38(50.7%) 6(8%) 56(74.7%) 13(17.3%) 24(32%) 51(68%) 0 15(20%) 60(80%)
HIV-negative 41 (100%) 4(9.8%) 31(75.6%) 6(14.6%) 4(9.8%) 29(70.7%) 8(19.5%) 5(12.2%) 36(87.8%) 1(2.5%) 7(17%) 33(80.5%)
Scores for phospholipase, proteinase and haemolytic activity: 1, showed no enzymatic activity (Hi, Pz, Prz = 1); 2, moderate enzyme activity (0.63 < Hi, Pz, Prz < 0.99); 3, high
enzymatic activity (Hi, Pz, Prz  0.63).
Table 2
Comparison of the average activity of phospholipase, proteinase and haemolytic
activity among isolates of C. albicans from the HIV-positive and HIV-negative
groups.
Enzyme HIV positive (75) HIV-negative (41) P
Mean  SD Mean  SD
Phospholipase 0.660  0.08 0.698  0.9 0.0114
Proteinase 0.714  0.08 0.703  0.08 0.7179
Haemolytic activity 0.414  0.12 0.420  0.15 0.7556
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isolates (Table 1).
The enzyme activities produced by the isolates are shown in
Table 2. Comparing the activity of the four enzymes between
groups of individuals with and without HIV, phospholipase activity
was more intense for the group consisting of HIV positive
individuals (P = 0.0114). When was analyzing the isolated enzyme
producers or not only the production of DNAse (P = 0.0002) was
more frequent also in the group of HIV-positive individuals
(Table 2).
Regarding the use of HAART in the HIV-positive group, it was
observed that most patients (86%) used some therapeutic regimen
at the time of collection of saliva samples, with the predominant
therapy combining the use of a reverse transcriptase inhibitor and
a protease inhibitor. Although no statistically signiﬁcant difference
was found in the intensity of the activity of the exoenzymes
phospholipase, proteinase and haemolysin according to the type of
HAART used, it was observed that the mean haemolytic and
phospholipase activity was slightly more intense among individu-
als who were not taking anti-retrovirals than in the two groups
with HAART regimens (Table 3).
When the same analysis was performed for DNase activity in
relation to different HAART regimens, a statistically signiﬁcant
difference was found between the group of patients who did not use
any antiretrovirals and the group who used transcriptase inhibitors
(IT) (P = 0.037) and the isolates from the group using at least one
reverse transcriptase inhibitor associated with protease inhibitor
(PI) (P = 0.011) (Table 3). DNase activity was more frequent among
isolates from the group of patients who did not use HAART. Twenty
percent of the isolates from patients using IP and IT, 33.3% of the
individuals using IT only, and 66.6% of the isolates from those not
using of HAART were positive for DNAse (Table 3).
4. Discussion
C. albicans has physiological characteristics that promote
colonisation and tissue invasion. The exoenzymes phospholipase,
proteinase and DNAse, and the exotoxin haemolysin, are virulence
factors that contribute to the yeast pathogenicity (Pakshir et al.,
2013; Mane et al., 2011). Studies have shown that C. albicans
isolates from different clinical samples produce one or more of
these virulence factors with a greater or lesser frequency
depending on the place of isolation, the clinical condition of the
patient, their immune status and the therapeutic regimen (Giolo &
Svidzinski, 2010).
In the present study, C. albicans isolates from HIV-infected
individuals had a higher frequency of expression of the four
virulence factors studied (the exoenzymes phospholipase, pro-
teinase and DNAse, and the exotoxin haemolysin) than those
isolates from HIV-negative individuals.
Phospholipase activity has been demonstrated in C. albicans
isolates from different anatomical sites and different groups ofindividuals (Riceto et al., 2015; Junqueira et al., 2012; Mahmou-
dabadi, Zarrin & Miry, 2010; Tsang et al., 2007; Price et al., 1982).
These ﬁndings corroborate the reports of Back-Brito et al. (2011)
that showed similar results in isolates from individuals under the
same conditions, so the phospholipase activity is a virulence factor
which has the greatest expression in isolated HIV-infected
individuals.
Another virulence factor analysed in this study was proteinase
activity. Proteinases are expressed by the majority of C. albicans
isolates from different clinical specimens varying from 70 to 100%
of isolates (Ramos et al., 2014; Junqueira et al., 2012). The activity of
the enzyme, however, is variable in different studies. In the present
study most of the isolates showed moderate proteinase activity. By
contrast, Sardi et al. (2013) observed that all isolates isolated from
the oral cavity of people with diabetes showed proteinase activity.
The expression and enzyme activity seems to be inﬂuenced by high
carbohydrate diets, which reduce the oral pH, and induce the
expression of the enzyme, but also by the host immune condition
(Mane et al., 2011; Marija, 2008; Tsang et al., 2007; Wu &
Samaranayake, 1999).
Research into haemolytic activity in Candida spp. is relatively
recent in the study of virulence factors, and because the stand-
ardisation of the methodology is still under discussion, conﬂicting
results may be obtained from similar studies. It is believed that the
expression of haemolysin is an inherent factor for Candida species
which is triggered under speciﬁc conditions (Favero et al., 2014). In
this study, only one isolate of C. albicans from the uninfected group
showed no haemolytic activity, and most isolates of both groups
showed accentuated activity. The haemolytic activity of C. albicans
isolates has been demonstrated in studies performed by Mane et al.
(2011) and Tsang et al. (2007). The ﬁrst study analysed yeasts from
the oral cavity of HIV-positive patients and found that all 39
isolates of C. albicans evaluated were positive for haemolytic
activity. Similarly, Tsang et al. (2007), in a study of 126 isolates of C.
albicans from the oral cavity of individuals with type 2 diabetes and
a control group observed that all isolates had haemolytic activity.
In both cases the methodology used to perform the tests was
similar. As the iron ion is essential in the mammalian respiratory
process, it may also be important for the vital functions of yeasts
and their multiplication. This hypothesis may explain the high
number of isolates positive for haemolytic activity found in
different studies (Manns et al., 1994).SD, standard deviation.
Table 3
Frequency and average activity of phospholipase, proteinase, haemolysin and DNase from C. albicans isolates from the oral cavity of HIV patients and the antiretroviral therapy
used.
Enzyme Therapeutic regimen— HAART Activity positive n (%) Mean EA/SD P value
Phospholipase IT + IP (35) 34 (97.1%) 0.655  0.07 0.547
IT (30) 30 (100%) 0.670  0.08
IT + IP + II (1) 1 (100%) 0.75
Not used (9) 9 (100%) 0.637  0.08
Proteinase IT + IP (35) 33 (94.3%) 0.698  0.08 0.368
IT (30) 28 (93.3%) 0.729  0.08
IT + IP + II (1) 1 (100%) 0.755
Not used (9) 7 (77.7%) 0.723  0.11
Haemolysin IT + IP (35) 35 (100%) 0.415  0.12 0.902
IT (30) 30 (100%) 0.419  0.13
IT + IP + II (1) 1 (100%) 0.425
Not used (9) 9 (100%) 0.396  0.16
DNAse IT + IP (35) 7 (20%)
IT (30) 10 (33.3%)
IT + IP + II (1) 1 (100%)
Not used (9) 6 (66.6%)
IT: transcriptase inhibitor; IP: protease inhibitor; II: integrase inhibitor; EA: enzymatic activity; SD: standard deviation.
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mental and clinical isolates of Cryptococcus neoformans and C.
gattii, we observed DNase activity in all isolates (Sánchez & Colom,
2010). Reports of isolates of C. albicans with DNase activity were
not found in the literature. The DNAse enzyme activity in C.
albicans, the present study was observed in isolates of both groups,
but the frequency of positive isolates was signiﬁcantly higher in
the group of HIV-positive than in HIV-negative group. The reason
for this difference is not clear and more research is needed about
how and under what conditions its production is stimulated. Riceto
et al. (2015) reported that 26% of C. albicans isolates in blood,
synovial ﬂuid and peritoneal ﬂuids of hospitalised patients showed
DNAse activity. Perhaps the scarcity of reports is due to the
difﬁculty of demonstrating the enzyme activity, especially the
quantiﬁcation of the intensity of enzyme activity using similar
methodology to that used for phospholipase and proteinase. Thus,
the investigation of DNase activity in fungal isolates requires
standardisation and perfection of technique to improve the
sensitivity of the detection of enzyme activity, and exploration
of the mechanisms of action of the enzyme. What role DNAse plays
in the expression of invasive candidiasis is not yet fully known, but
based on the results of this study, it is clear that the C. albicans
strains that colonise the HIV positive individuals have a greater
potential for DNase activity, compared with those isolated from
cases without HIV.
With the advent of HAART, there was a reduction in the
occurrence of yeast infections among individuals with HIV
(Esebelahie, Enweani & Omoregie, 2013; Back-Brito et al., 2011;
Costa et al., 2006). Some authors report that antiretroviral drugs of
the protease inhibitor class promote the reduction of protease
activity as some enzymes produced by Candida spp., such as the
aspartyl proteinase (SAP), are from the same family as HIV
proteinases (De Bernadis et al., 2004; Ribeiro, Miranda, Gambale &
Paula, 2004). Although the average activity of the phospholipase,
proteinase, DNAse and haemolysin was similar in those isolated
from both groups, the number of isolates with moderate to
accentuated activity of haemolysin protein of both groups was very
similar. For phospholipase activity isolates from HIV patients had a
greater number with marked activity. DNase activity was also more
frequent among HIV-positive isolates.
However, when we evaluated the activity of these exoenzymes
in the isolates from HIV-positive individuals according to the
HAART used, a slightly greater phospholipase and haemolyticactivity was observed in C. albicans from individuals who did not
use any antiretrovirals. Similarly, a signiﬁcantly higher expression
of DNase was observed in isolates from individuals who did not use
any HAARTcompared with isolates from patients using a treatment
regimen. Thus in can be inferred that although the exoenzyme
activity was higher among isolates of HIV-positive individuals,
HAART somehow reduced the expression of the three exoenzymes
cited. This may have occurred due to an improvement in the
functioning of the immune system caused by the use of
antiretroviral drugs.
It is also possible that the DNAse expression was signiﬁcantly
lower among isolates from individuals using HAART because
antiretrovirals of the transcriptase inhibitor class act directly on
the virus’s genetic material and may exert an inﬂuence on the DNA
of yeast preventing expression of genes responsible for the
production of DNase.
Protease activity was more marked among subjects receiving
HAART (particularly IT + IP), contrary to the hypothesis that
antiretroviral protease inhibitors could decrease the expression of
proteinases produced by Candida spp. (De Bernadis et al., 2004;
Ribeiro et al., 2004). Similar results were found by Bosco, Birman,
Cury and Paula (2003) and Back-Brito et al. (2011). Perhaps the
reason for anti retrovirals not inhibiting the expression of this
enzyme is the fact that among the numerous different classes of
proteinases being expressed by isolates studied there are some on
which HAART has no effect. Furthermore, as most of the isolates
were obtained from individuals who had been HIV positive for many
years, many may have used antifungal drugs in the treatment of
fungal infections, or as prophylactics to prevent the recurrence of
cryptococcosis or candidiasis, for example. This may have led to
selection of strains of the enzymes studied on which HAART has no
action. Thus, other studies are necessary, designed to evaluate more
thoroughly the role of HAART in the expression of these enzymes.
The isolates of C. albicans, both from HIV-positive individuals
and those without HIV, showed activity of the enzymes studied,
but the frequency and intensity varied. The activities of proteinase
and haemolysin were similar in both groups, however, phospholi-
pase activity was more marked in isolates from HIV patients. The
production of DNase was more frequent among isolates of HIV-
infected individuals. Thus, it can be concluded that isolates of C.
albicans from the saliva of HIV patients have greater phospholipase
activity, and express DNase activity more frequently than isolates
from HIV-negative individuals. Under the conditions of this study,
R. de Paula Menezes et al. / Archives of Oral Biology 66 (2016) 61–65 65it was shown that the use of HAART had a signiﬁcant effect on the
expression of DNase, but did not reduce the activity of other
enzymes studied.
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